Public signalCompany raiseAuto-indexed · Unverified
Nasus Pharma Ltd raised $15.0M
Nasus Pharma Ltd· TEL AVIV, ISRAEL· Biotechnology· Filed Feb 25, 2026
Nasus Pharma Ltd reported raising capital. Based in TEL AVIV, ISRAEL. First sale reported 2026-02-10. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$15.0M
Confidence90%
Raised
$15.0M
Investors
15
Jurisdiction
ISRAEL
On the record
- Location
- TEL AVIV, ISRAEL
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $15.0M
- Target amount
- $15.0M
- Filing date
- Feb 25, 2026
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- ISRAEL
- Industry group
- Biotechnology
- Number of investors
- 15
- Includes non-accredited investors
- No
- Revenue range
- No Revenues
- Total offering amount
- $15.0M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Dalia Megiddo
Director
TEL AVIV, ISRAEL
Dan Teleman
Executive Officer
TEL AVIV, ISRAEL
David Silberman
Director
TEL AVIV, ISRAEL
Eyal Rubin
Executive Officer
TEL AVIV, ISRAEL
Isaac Israel
Director
TEL AVIV, ISRAEL
Ronnie Hershman
Director
TEL AVIV, ISRAEL
Sharon Shacham
Director
TEL AVIV, ISRAEL
Udi Gilboa
Director
TEL AVIV, ISRAEL
Sources & provenance
“Operating company sold 15,000,040 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Feb 25, 2026. Details beyond the filing have not been verified.
Tags
ISRAELCompanyBiotechnology$10M – $100MCompany Raise
Are you associated with Nasus Pharma Ltd?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record